National Stroke Foundation

Panretin Gel

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved June 1999

Specific Treatments:

Infectious Diseases

Therapeutic Areas

General Information

Panretin (alitretinoin) Gel, 0.1%, has been approved for the treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma.